Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1964 1
1965 2
1972 2
1980 1
1982 1
1984 1
1990 3
1991 1
1993 1
1994 3
1995 4
1996 3
1997 2
1998 6
1999 4
2000 1
2001 4
2002 5
2003 5
2004 2
2005 7
2006 6
2007 5
2008 9
2009 8
2010 5
2011 6
2012 4
2013 3
2014 3
2015 3
2016 6
2017 7
2018 3
2019 7
2020 8
2021 7
2022 5
2023 4
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

153 results

Results by year

Filters applied: . Clear all
Page 1
Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial.
Lombardi G, De Salvo GL, Brandes AA, Eoli M, Rudà R, Faedi M, Lolli I, Pace A, Daniele B, Pasqualetti F, Rizzato S, Bellu L, Pambuku A, Farina M, Magni G, Indraccolo S, Gardiman MP, Soffietti R, Zagonel V. Lombardi G, et al. Among authors: farina m. Lancet Oncol. 2019 Jan;20(1):110-119. doi: 10.1016/S1470-2045(18)30675-2. Epub 2018 Dec 3. Lancet Oncol. 2019. PMID: 30522967 Clinical Trial.
Eligible patients (aged 18 years) with histologically confirmed glioblastoma, Eastern Cooperative Oncology Group performance status 0 or 1, and documented disease progression after surgery followed by radiotherapy and temozolomide chemoradiotherapy were randomly assigned ( …
Eligible patients (aged 18 years) with histologically confirmed glioblastoma, Eastern Cooperative Oncology Group performance status 0 …
CXCL8/CXCR2 signaling mediates bone marrow fibrosis and is a therapeutic target in myelofibrosis.
Dunbar AJ, Kim D, Lu M, Farina M, Bowman RL, Yang JL, Park Y, Karzai A, Xiao W, Zaroogian Z, O'Connor K, Mowla S, Gobbo F, Verachi P, Martelli F, Sarli G, Xia L, Elmansy N, Kleppe M, Chen Z, Xiao Y, McGovern E, Snyder J, Krishnan A, Hill C, Cordner K, Zouak A, Salama ME, Yohai J, Tucker E, Chen J, Zhou J, McConnell T, Migliaccio AR, Koche R, Rampal R, Fan R, Levine RL, Hoffman R. Dunbar AJ, et al. Among authors: farina m. Blood. 2023 May 18;141(20):2508-2519. doi: 10.1182/blood.2022015418. Blood. 2023. PMID: 36800567 Free PMC article.
Proinflammatory signaling is a hallmark feature of human cancer, including in myeloproliferative neoplasms (MPNs), most notably myelofibrosis (MF). Dysregulated inflammatory signaling contributes to fibrotic progression in MF; however, the individual cytokine mediators eli …
Proinflammatory signaling is a hallmark feature of human cancer, including in myeloproliferative neoplasms (MPNs), most notably myelo …
How Radiomics Can Improve Breast Cancer Diagnosis and Treatment.
Pesapane F, De Marco P, Rapino A, Lombardo E, Nicosia L, Tantrige P, Rotili A, Bozzini AC, Penco S, Dominelli V, Trentin C, Ferrari F, Farina M, Meneghetti L, Latronico A, Abbate F, Origgi D, Carrafiello G, Cassano E. Pesapane F, et al. Among authors: farina m. J Clin Med. 2023 Feb 9;12(4):1372. doi: 10.3390/jcm12041372. J Clin Med. 2023. PMID: 36835908 Free PMC article. Review.
Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms.
Dunbar AJ, Bowman RL, Park YC, O'Connor K, Izzo F, Myers RM, Karzai A, Zaroogian Z, Kim WJ, Fernandez-Maestre I, Waarts MR, Nazir A, Xiao W, Codilupi T, Brodsky M, Farina M, Cai L, Cai SF, Wang B, An W, Yang JL, Mowla S, Eisman SE, Hanasoge Somasundara AV, Glass JL, Mishra T, Houston R, Guzzardi E, Martinez Benitez AR, Viny AD, Koche RP, Meyer SC, Landau DA, Levine RL. Dunbar AJ, et al. Among authors: farina m. Cancer Discov. 2024 Jan 12. doi: 10.1158/2159-8290.CD-22-0952. Online ahead of print. Cancer Discov. 2024. PMID: 38230747 Free article.
Gain-of-function mutations activating JAK/STAT signaling are seen in the majority of patients with myeloproliferative neoplasms (MPNs), most commonly JAK2V617F. While clinically-approved JAK inhibitors improve symptoms and outcomes in MPNs, remissions are rare, and mutant …
Gain-of-function mutations activating JAK/STAT signaling are seen in the majority of patients with myeloproliferative neoplasms (MPNs …
Regret and Quality of Life After Mastectomy With or Without Reconstruction.
Fortunato L, Loreti A, Cortese G, Spallone D, Toto V, Cavaliere F, Farina M, La Pinta M, Manna E, Detto L, Pallara T. Fortunato L, et al. Among authors: farina m. Clin Breast Cancer. 2021 Jun;21(3):162-169. doi: 10.1016/j.clbc.2019.11.005. Epub 2020 Oct 14. Clin Breast Cancer. 2021. PMID: 33744100
The possible role of mutated endothelial cells in myeloproliferative neoplasms.
Farina M, Russo D, Hoffman R. Farina M, et al. Haematologica. 2021 Nov 1;106(11):2813-2823. doi: 10.3324/haematol.2021.278499. Haematologica. 2021. PMID: 34320782 Free PMC article. Review.
Myeloproliferative neoplasms (MPN) are chronic, clonal hematologic malignancies characterized by myeloproliferation and a high incidence of vascular complications (thrombotic and bleeding). ...
Myeloproliferative neoplasms (MPN) are chronic, clonal hematologic malignancies characterized by myeloproliferation and a high incide …
Pembrolizumab in the treatment of advanced urothelial cancer.
Lundgren KT, Farina MS, Bellmunt J. Lundgren KT, et al. Among authors: farina ms. Future Oncol. 2017 Dec;13(30):2745-2758. doi: 10.2217/fon-2017-0284. Epub 2017 Sep 12. Future Oncol. 2017. PMID: 29219016 Review.
Computational challenges of tumor spheroid modeling.
Chignola R, Fabbro AD, Farina M, Milotti E. Chignola R, et al. Among authors: farina m. J Bioinform Comput Biol. 2011 Aug;9(4):559-77. doi: 10.1142/s0219720011005379. J Bioinform Comput Biol. 2011. PMID: 21776609 Review.
153 results